Elevated levels of serum PCSK9 in male patients with symptomatic peripheral artery disease: The CAVASIC study

This publication has 48 references indexed in Scilit:

• Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study
  European Journal of Preventive Cardiology, 2014
• Lipoprotein(a): resurrected by genetics
  Journal of Internal Medicine, 2012
• Gene Inactivation of Proprotein Convertase Subtilisin/Kexin Type 9 Reduces Atherosclerosis in Mice
  Circulation, 2012
• Lipoprotein(a), Inflammation, and Peripheral Arterial Disease in a Community-Based Sample of Older Men and Women (the InCHIANTI Study)
  The American Journal of Cardiology, 2010
• Mortality and Vascular Morbidity in Older Adults With Asymptomatic Versus Symptomatic Peripheral Artery Disease
  Circulation, 2009
• Variation in PCSK9, low LDL cholesterol, and risk of peripheral arterial disease
  Atherosclerosis, 2009
• Association between the UGT1A1 TA-Repeat Polymorphism and Bilirubin Concentration in Patients with Intermittent Claudication: Results from the CAVASIC Study
  Clinical Chemistry, 2008
• Increased Serum Lipoprotein(a) Concentrations and Low Molecular Weight Phenotypes of Apolipoprotein(a) Are Associated with Symptomatic Peripheral Arterial Disease
  Clinical Chemistry, 2007
• Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
  Journal of Vascular Surgery, 2007
• Lipoprotein(a)- and low-density lipoprotein–derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy?
  Kidney International, 2004